Correlation Between FactSet Research and Albireo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FactSet Research and Albireo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FactSet Research and Albireo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FactSet Research Systems and Albireo Pharma, you can compare the effects of market volatilities on FactSet Research and Albireo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FactSet Research with a short position of Albireo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of FactSet Research and Albireo Pharma.

Diversification Opportunities for FactSet Research and Albireo Pharma

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between FactSet and Albireo is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding FactSet Research Systems and Albireo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Albireo Pharma and FactSet Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FactSet Research Systems are associated (or correlated) with Albireo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Albireo Pharma has no effect on the direction of FactSet Research i.e., FactSet Research and Albireo Pharma go up and down completely randomly.

Pair Corralation between FactSet Research and Albireo Pharma

Considering the 90-day investment horizon FactSet Research is expected to generate 16.37 times less return on investment than Albireo Pharma. But when comparing it to its historical volatility, FactSet Research Systems is 6.93 times less risky than Albireo Pharma. It trades about 0.05 of its potential returns per unit of risk. Albireo Pharma is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1,811  in Albireo Pharma on December 19, 2023 and sell it today you would earn a total of  2,604  from holding Albireo Pharma or generate 143.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy29.57%
ValuesDaily Returns

FactSet Research Systems  vs.  Albireo Pharma

 Performance 
       Timeline  
FactSet Research Systems 

Risk-Adjusted Performance

7 of 100

 
Low
 
High
OK
Compared to the overall equity markets, risk-adjusted returns on investments in FactSet Research Systems are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent fundamental indicators, FactSet Research may actually be approaching a critical reversion point that can send shares even higher in April 2024.
Albireo Pharma 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Albireo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Albireo Pharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

FactSet Research and Albireo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FactSet Research and Albireo Pharma

The main advantage of trading using opposite FactSet Research and Albireo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FactSet Research position performs unexpectedly, Albireo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will offset losses from the drop in Albireo Pharma's long position.
The idea behind FactSet Research Systems and Albireo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk